XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 6,178 $ 2,268
Contract and other receivables, net 727 990
Costs and estimated earnings in excess of billings on uncompleted contracts 154 223
Inventories, net 108 134
Prepaid expenses and other current assets 266 114
Total current assets 7,433 3,729
Property and equipment, net 390 418
Goodwill 780 1,907
Other intangible assets, net 398 561
Other assets 109 112
Total assets 9,110 6,727
Current Liabilities:    
Accounts payable and accrued expenses 2,390 2,841
Deferred revenues 2,181 2,494
Total current liabilities 4,571 5,335
Long-term borrowings 1,838 1,656
Deferred revenues – noncurrent portion 112
Other liabilities 108 41
Total liabilities 6,629 7,032
Commitments and Contingencies
Stockholders’ Equity (Deficiency):    
Preferred stock, $.0001 par value, 1,000 shares authorized; none issued
Common stock, $.0001 par value, 49,000 shares authorized; 17,520 and 16,316 issued; 16,743 and 15,547 outstanding at December 31, 2018 and 2017, respectively 2 2
Additional paid-in capital 69,241 68,886
Treasury stock 777 and 769 shares at cost at December 31, 2018 and, 2017, respectively (1,542) (1,536)
Accumulated deficit (65,220) (67,657)
Total stockholders' equity (deficiency) 2,481 (305)
Total liabilities and stockholders’ equity (deficiency) $ 9,110 $ 6,727